Roche’s recently launched cobas pro integrated solutions have now become available in countries that accept the CE mark in Europe.

Claimed to be the next generation of innovation in the serum work area, Roche’s solution is expected to boost clinical outcomes that will improve patient care as well as enhance operator experience by helping to streamline and simplify equipment and processes.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Additionally, with an easy to use and newly designed interface, the cobas pro integrated solutions reduce the cost of healthcare delivery.

“Roche’s solution is expected to boost clinical outcomes that will improve patient care as well as enhance operator experience by helping to streamline and simplify equipment and processes.”

It enables up to 2,200 tests in an hour even with three modules working in parallel. These modules are synchronised to bolster efficiency.

Roche Diagnostics Centralised and Point of Care Solutions head Thomas Schinecker said: “This new generation of Serum Work Area solutions has been inspired by our tireless mission to help improve speed and reliability of treatment decisions for patients and their families.

“To achieve this, we strive to simplify the workflow of our customers so they can carry out their daily routine efficiently. Increasing automation and minimising operation intervention with cobas pro integrated solutions will not only improve productivity but also enhance reliability and turnaround times in delivering results to patients”.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Additionally, it boasts up to 3.25 hours less operating time, with 93% of Roche Immunoassays having reaction times of 18 minutes or even less.

Reducing the time in delivering results to doctors and patients across several therapeutic areas, including pregnancy, core lab/HIV testing and blood screening, is essential for taking a clinical decision.

The new solutions come with advanced features including automated maintenance and cobas AutoCal, along with an intelligent, on-the-fly reagent loading concept.

These features have been incorporated after drawing insights from customers of Roche Diagnostics.

They aim to optimise the daily experience of laboratory professionals, thereby enabling them to focus their time on the tasks that are urgent and spending less time on manual operations.

The cobas pro integrated solutions include innovations such as cobas SonicWash, which is an ultrasonic probe cleaning on the Clinical Chemistry and Ion-Selective Electrode analytical units to ensure sample integrity and flexible sample routing.

The cobas AutoCal is an automated calibration procedure on the clinical chemistry analytical unit which reduces hands-on time.  These features ensure to reduce the time between diagnosis and treatment plans.

Medical Device Network Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Medical Device Network Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving medical devices advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now